Tissue distribution of the opioid receptor-like (ORL1) receptor

被引:201
|
作者
Mollereau, C [1 ]
Mouledous, L [1 ]
机构
[1] Inst Pharmacol & Biol Struct, F-31077 Toulouse, France
关键词
neuropeptide; nociceptin or orphanin FQ; ORL1; receptor; G protein-coupled receptor; anatomic distribution;
D O I
10.1016/S0196-9781(00)00227-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ORL1 receptor is a G protein-coupled receptor structurally related to the opioid receptors, whose endogenous ligand is the heptadecapeptide nociceptin/orphanin FQ. In this review, data which have contributed to the mapping of the anatomic distribution of the ORL1 receptor have been collated with an emphasis on their relation to physiological functions. The ORL1 receptor is widely expressed in the central nervous system, in particular in the forebrain (cortical areas, olfactory regions, limbic structures, thalamus), throughout the brainstem (central periaqueductal gray, substantia nigra, several sensory and motor nuclei), and in both the dorsal and ventral horns of the spinal cord. Regions almost devoid of ORL1 receptors are the caudate-putamen and the cerebellum ORL1 mRNA and binding sites exhibit approximately the same distribution pattern, indicating that the ORL1 receptor is located on local neuronal circuits. The ORL1 receptor is also expressed at the periphery in smooth muscles, peripheral ganglia, and the immune system. The anatomic distribution of ORL1 receptor suggests a broad spectrum of action for the nociceptin/orphanin FQ system (sensory perception, memory process, emotional behavior, etc.). (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:907 / 917
页数:11
相关论文
共 50 条
  • [21] Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors
    Zaveri, N
    Polgar, WE
    Olsen, CM
    Kelson, AB
    Grundt, P
    Lewis, JW
    Toll, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 428 (01) : 29 - 36
  • [22] In Silico Study of the Structurally Similar ORL1 Receptor Agonist and Antagonist Pairs Reveal Possible Mechanism of Receptor Activation
    Sencanski, Milan
    Dosen-Micovic, Ljiljana
    PROTEIN JOURNAL, 2014, 33 (03) : 231 - 242
  • [23] Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat
    Champion, HC
    Czapla, A
    Kadowitz, PJ
    PEPTIDES, 1997, 18 (05) : 729 - 732
  • [24] Involvement of nociceptin/orphanin FQ in release of hypothalamic GnRH mediated by ORL1 receptor in ovariectomized rats
    Xiao-fei AN Hai-ping CHEN Shu-lan MA Yi FENG Jun-wei HAO Bo-ying CHEN~1 Department of Neurobiology and Integrative Medicine
    Acta Pharmacologica Sinica, 2005, (09) : 1039 - 1044
  • [25] Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat
    Czapla, MA
    Champion, HC
    Kadowitz, PJ
    PEPTIDES, 1997, 18 (06) : 793 - 795
  • [26] Involvement of nociceptin/orphanin FQ in release of hypothalamic GnRH mediated by ORL1 receptor in ovariectomized rats
    An, XF
    Chen, HP
    Ma, SI
    Feng, Y
    Hao, JW
    Chen, BY
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (09) : 1039 - 1044
  • [27] Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro
    Werthwein, S
    Bauer, U
    Nakazi, M
    Kathmann, M
    Schlicker, E
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (01) : 300 - 308
  • [28] Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function
    Higgins, GA
    Grottick, AJ
    Ballard, TM
    Richards, JG
    Messer, J
    Takeshima, H
    Pauly-Evers, M
    Jenck, F
    Adam, G
    Wichmann, J
    NEUROPHARMACOLOGY, 2001, 41 (01) : 97 - 107
  • [29] Pertussis toxin-insensitive signaling of the ORL1 receptor:: Coupling to Gz and G16 proteins
    Chan, JSC
    Yung, LY
    Lee, JWM
    Wu, YL
    Pei, G
    Wong, YH
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (05) : 2203 - 2210
  • [30] A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397
    Ozaki, S
    Kawamoto, H
    Itoh, Y
    Miyaji, M
    Iwasawa, Y
    Ohta, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (03) : R17 - R18